Screener
Xtant Medical Holdings XTNT EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Xtant Medical Holdings in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: Xtant Medical Holdings’s 10-Q, filed August 11, 2026.
- Filed
- Aug 11, 2026, 7:15 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001493152-26-036981
| Line item | 2026 / Three Months Ended June 30, | 2025 / Three Months Ended June 30, | 2026 / Six Months Ended June 30, | 2025 / Six Months Ended June 30, |
|---|---|---|---|---|
| Provision for Income Taxes Current and Deferred | (73) | (255) | (100) | (230) |
| Net (Loss) Income | $(9,413) | $3,550 | $(12,502) | $3,608 |
| Net (Loss) Income Per Share: | ||||
| Basic | $(0.07) | $0.03 | $(0.09) | $0.03 |
| Dilutive | $(0.07) | $0.02 | $(0.09) | $0.02 |
| Shares used in the computation: | ||||
| Basic | 140,258,667 | 139,310,589 | 140,159,255 | 139,190,378 |
| Dilutive | 140,258,667 | 148,574,242 | 140,159,255 | 148,339,423 |
ITEM 1. Item 1. FINANCIAL STATEMENTS FINANCIAL STATEMENTS
FAQ
- What is Xtant Medical Holdings's EPS (diluted)?
- Xtant Medical Holdings (XTNT) reported EPS (diluted) of -$0.07 in Q2 2026.
- How has Xtant Medical Holdings's EPS (diluted) changed year-over-year?
- Xtant Medical Holdings's EPS (diluted) decreased by 450.0% year-over-year, from $0.02 to -$0.07.
- What is the long-term trend for Xtant Medical Holdings's EPS (diluted)?
- Over 3 years (2021 to 2025), Xtant Medical Holdings's EPS (diluted) has grown at a -20.6% compound annual growth rate (CAGR), from -$0.06 to $0.03.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about Xtant Medical Holdings's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude